Javascript Required
Your browser must have Javascript enabled in order for our dynamic player to be embedded. Please turn on Javascript in your browser preferences and then refresh this page.

Related Videos (24) - hide

Related Organizations

Physician Insight:
About the TPV procedure

The Cardiovascular Program at Children's Hospital Boston is a world leader in pediatric cardiology and cardiac surgery, and has pioneered treatments that have dramatically improved the survival rate for fetuses, infants, children, teens and adults with congenital or acquired heart defects. Watch Children's back-to-back Webcasts live from our cath lab and cardiac OR.

On October 4 at 9 am EDT Cardiologists from Children's Hospital Boston will implant a Transcatheter Pulmonary Valve (TPV), currently in clinical trial at Children's Hospital Boston and two other pediatric hospitals in the United States. This non-surgical treatment restores effective pulmonary valve function and potentially prolongs the functional life of regurgitant and/or stenotic right ventricle to pulmonary artery conduits. Children's has one of the largest pediatric Cardiac Catheterization Programs in the country, performing over 1,500 cardiac catheterization procedures per year.

On October 5th at 1 p.m. EDT – Cardiac surgeons from Children's Hospital Boston will repair a complex congenital cardiac defect during the live broadcast. The operation will take place in one of three operating rooms at Children's dedicated to cardiac surgical procedures. Each year, the Pediatric Cardiac Surgery Program provides surgical care to approximately 1,100 patients, including more than 700 cases of open-heart surgery (that require cardiopulmonary bypass) and 400 closed-cases (that do not require bypass), with extraordinary success rates.

Both Webcasts are part of this year's "Frontiers in Diagnosis & Management of Congenital Heart Disease," taking place at Children's Hospital Boston. The conference will focus on review of catheter-based and surgical treatment options for congenital heart disease as well as current developments in intensive care management and cardiac surgery research. For more information, visit



Peter Lang

Peter Lang, MD

James Lock

James Lock, MD

Doff McElhinney

Doff McElhinney, MD